Enzymatic Nicotine Degradation Platform

Patent Application No. 63/927,590

A first-of-its-kind approach to reducing nicotine exposure through enzymatic degradation in smoke, vapor, and aerosol streams using optimized nicotine-oxidizing enzymes and immobilized systems.

Glucose-Responsive RNAi Delivery Platform

Patent Application No. 63/931,994

A smart microcapsule system that enables glucose-triggered delivery of RNAi and nucleic-acid therapeutics, offering precision treatment potential for metabolic disorders.